SRF and liver cancer: Similar to the RBC‐EVs/Dox, the RBC‐EVs/SRF exhibited a better therapeutic effect on HCC‐LM3 orthotopic liver cancer than the RD/SRF, and the SA/SRF showed no therapeutic effect (Figure 5G).